drug metabolism refers to enzyme-mediated biotransformations (detoxication) that alter the...

48
Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds. D rug M etabolic enzym es M etabolite

Upload: abigail-simmons

Post on 18-Dec-2015

216 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Drug metabolism

Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds.

DrugMetabolic enzymes

Metabolite

Page 2: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Drug metabolism

• Drugs undergo a variety of chemical changes in the animal organism by enzymes of the liver, intestine, kidney, lung, plasma and other tissues.

• Many enzymes take place in such biotransformations; oxidase, hydrolase, lipase, synthetase, dehydrogenase, …etc

Page 3: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Blood

CNS

Muscles

Heart

Page 4: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Metabolism may result in:

– Pharmacologically inactive drug (detoxification).

– Pharmacologically active drug (bioactivation…prodrug approach).

– Change the pharmacological activity (toxic effect).

Page 5: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

The importance of studying drug metabolism:

– Understanding the pharmacological and toxicological activity of drugs.

– The importance of shortening the drug’s duration of action.

– The complications of drug-drug interactions mainly depends on the induction or inhibition of metabolic enzymes

Page 6: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Drug metabolism

• Can be divided into two distinct categories:

– Phase-I: Reactions which introduce or unmask hydrophilic

groups in the drug structure (functionalisations).

– Phase-II: Reactions which conjugate the drug or its phase-I

metabolite with a hydrophilic, endogenous species (conjugation reactions).

Page 7: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Phase-I reactions

• Aliphatic hydroxylation.• Oxidation:

– Oxidative Dealkylation.– Oxidative deamination.– N and S oxidation.– Alcohol/aldehyde dehydrogenase.

• Reduction.• Hydrolysis.

Page 8: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Phase-II metabolism

• Involves the following conjugation reactions that are catalyzed by transferase enzymes:

– Glucuronidation.– Sulfation.– Amino acid conjugation.– Methylation.– Acetylation.

Page 9: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Phase-I reactions

• Two general types of enzyme systems take part in these reactions:

– Microsomal Mixed Function Oxidases (MFOs)• Flavoprotein, NADPH-monooxygenase• Cytochrome P450

– Non-cytochrome oxidizing enzymes.• Xanthine oxidase• Alcohol/aldehyde dehydrogenase

Page 10: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

General features of Cytochrome P-450

• A large number of families (at least 18 in mammals) of cytochrome P-450 (abbreviated “CYP”) enzymes exists as well as many subfamilies.

• each member catalyzes the biotransformation of a unique group of drugs

• some overlap in the substrate specificities.

Page 11: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

CYP 450Families and subfamilies

Foye's principles of medicinal chemistry

Page 12: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

CYP Biotransformations

• Chemically diverse small molecules are converted, generally to more polar compounds

• Reactions include:

– Aliphatic hydroxylation, aromatic hydroxylation– Dealkylation (N-,O-, S-)– N-oxidation, S-oxidation– Deamination– Dehalogenation

Page 13: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Oxidative Phase-I involving cytochrome P-450 enzymes:

• Aliphatic hydroxylation:– Mainly occur on the ultimate (ω) or penultimate

(ω-1) carbon atom in the structure.– Also it occurs at an activated carbon atom, that is

next to sp , sp2 carbons:

RR

R

O

R R

Page 14: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Oxidative Phase-I involving cytochrome P-450 enzymes:

• Aliphatic hydroxylation:– Mainly occur on the ultimate (ω) or penultimate

(ω-1) carbon atom in the structure.– Also it occurs at an activated carbon atom, that is

next to sp , sp2 carbons:

RR

R

O

R R

Page 15: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Oxidative Phase-I involving cytochrome P-450 enzymes:

• Aromatic hydroxylation:

HN

HNO

O

C6H6

Phenytoin

HN

HNO

O

C6H6 OH

Phase-II conjugate

Page 16: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

• Aromatic epoxidation:

Benzo[a]pyrene

ONH

N

N

N

N

O

Covalently bound Deoxyguanosine adduct(systemic toxicity)

O

HO

OH

Deoxyribose

NH

N

N

N

N

O

Deoxyribose

DNA

Page 17: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Oxidative Phase-I involving cytochrome P-450 enzymes:

• Alkene epoxidation:

N

O NH2

Carbamazipine

N

O NH2

O

N

O NH2

HOOH

HN

NH

O

O O

Secobarbital

HN

NH

O

O O

OH

HO

Secodiol

Page 18: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Glutathione conjugation

• For electrophilic drugs and metabolites:

G-SHO

R R SG

HH H HOH

G-SH O OH

SG

HS

NH

O COOH

HNH O

COOHNH2

Glutathione (tripeptide: glutamate+cysteine+glycine)

Page 19: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Detoxication by glutathione adduct formation

OH

O

O

N

O GSH

OH

O

O

N

GS

HO

[O]

O

Arene oxide

OH

SG

Page 20: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Glutathione conjugation

• Toxicity of aromatic compounds came from the formation of arene oxide during the metabolism that will be attacked by endogenous nucleophile such as proteins, DNA or RNA.

Page 21: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Glutathione conjugation

O

O

HH

NIH

Shift

OH

H2O

Or epoxide hydrolase

OH

OH

GSHOH

SG

DNA, RNA, proteins

OH

M

Page 22: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

• O-dealkylation:

O

N

O

OH

CH3

O

N

HO

OH

Oxidative demethylation

Codeine Morphine

Page 23: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

• N-dealkylation:

HN R

OH

NH2R

O

H

Page 24: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

N-dealkylation

Cl

N

N

C6H6

Cl

N

NH

C6H6

N-t-butylnorchlorcyclizine norchlorcyclizine

Br

N

Br

NH2

Br

O

OH

Brompheniramine

Page 25: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Oxidative Phase-I involving cytochrome P-450 enzymes:

• Oxidative deamination:

Page 26: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Oxidative Phase-I involving cytochrome P-450 enzymes:

• N-oxidation:– Mostly for primary and secondary amines as well

as aromatic amines:– This gives N-oxide that will be rapidly converted to

hydroxylamines.

Page 27: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

R NH2 R NH

OHR NO2

NH2HN

OHN

O

proteins and nucleic acids

NO2

N

OH

Protein

Oxidize Fe+2 in hemoglobin to Fe+3

(methemoglobin or ferrhemoglobin)

this form is no longer capable to transport oxygen

(methemoglobinemia toxicity)

NO

Page 28: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

HNO

2-acetylaminofluorene

NOHO

NO

-O3SO

Sulfate

conjugation

NO

NO

Nu

|Nitrenium ion

NO

Nu

Page 29: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Hydrolytic phase-I metabolism

• By non-specific esterase and amidase enzymes that present in plasma, gut, liver and kidney.

• It has a beneficial role in most of prodrugs that after hydrolysis inside the body release the active form of the drug.

Page 30: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Ester vs. Amide bond

Ester bond is relatively weaker than amide bond, it will be rapidly hydrolyzed by esterase enzyme

R O

O

R NH

O

The reactivity of ester and amide bond depend on how much the carbonyl carbon is electropositive

Nitrogen atom is less electronegative than oxygen, so it will be waeker electron withdrawing atom

therefore, the crabonyl carbon attached to oxygen atom will be more electropositive, and more reactive toward nucleophilic attack of water molecule during hydrolysis.

Page 31: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Nucleophilic attack of hydroxide anion on ester and amide

R O

O

R NH

O

OH OH

Page 32: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Example

ProcaineShort acting local anesthetic

ProcainamideLong acting antiarrhythmic

T1/2 = 2.5-4.5 hrT1/2

= 40-84 second

Page 33: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Hydrolytic phase-I metabolism

• Examples of prodrugs activated by hydrolytic enzymes:

– Dipivefrine: is a di-tertbutylcarboxy ester of adrenaline…. More lipophilic… better penetration through the corneal membrane….then will be hydrolyzed to give the active form (adrenaline)

Page 34: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Why Dipifevrine has been prepared?

– Adrenaline is a polar drug….difficult access into the ocular cavity.

– Adrenaline has a generalized adrenergic effect…. Many side effects such as increase blood pressure, heart rate and bronchodilation.

– Dipifevrine is more lipophilic, better penetration… localized effect.

HO

HO

HN

OH

Adrenaline

Page 35: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Other phase-I metabolic enzymes

• Alcohol dehydrogenase and aldehyde dehydrogenase:

R

OH

R

O

H R

O

OH

Alcohol

dehydrogenase

Aldehyde

dehydrogenase

R

O

RNo oxidation

Page 36: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Other phase-I metabolism

• Heterocyclic ring oxidation:

• S-dealkylation:

O

NH

Phenmetrazine

O

NH

O

N

N N

HN

S

6-methylmercapropurine

N

N N

HN

SH

6-mercapropurine

Page 37: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Other phase-I metabolism

• Sulfoxidation: by flavin monooxygenase

N

S

N

Chlorpromazine

N

S

N

O

N

S

NH2

O

N

S

O

OHO

Deaminated metabolite Dealkylated metabolite

Page 38: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Other phase-I metabolism• Azoreduction:

NN

COOH

OH

S

HNN

O

O

Azulfidine

NH2

S

HNN

O

O

H2N

COOH

OH

P-aminosalicylic acidSulfapyridine

Antibacterial action Anti-inflammatory action

Page 39: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

General notes regarding phase-I metabolism

• Hydrolysis normally catalyzed by carboxylesterases:– Cholinesterase…. Hydrolyzes choline-like esters (such

as succinylcholine), procaine and acetylsalicylic acid.

– Arylcarboxyesterase.– Liver carboxyesterase

O

O

O

O

N

N

Syccinylcholine

OH

O

OH

O

NHO

N

COOC2H5

HN

COO

Page 40: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

HN

COOCH3

HN

COOZwitter ionicPolarEasily excreted

Page 41: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

General notes regarding phase-I metabolism

• Esters that are sterically hindered are hydrolyzed more slowly and may be appeared unchanged in urine:

OH

O

O

N

Atropine

50% excreted unchanged in urine

Page 42: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

OH

O

O

N

Atropine

Page 43: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

General notes regarding phase-I metabolism

• Amides are more stable to hydrolysis than esters….large fraction of amide containing drugs are normally excreted unchanged.

H2N

NH

O

N

Procainamide

60% excreted unchanged in urine

Page 44: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

H2N

O

ON

Procaine

HN

O

N

Lidocaine

Procaine has a short duration of anesthesia

lidocaine has a long duration of anesthesia

Page 45: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

CH3

CH3

HN

O

N

Lidocaine

Nucleophilic attack of HO-

Page 46: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

Aromatic hydroxylation

• The least substituted aromatic ring will be favorably oxidized, especially at the least hindered carbon atom

• The activated ring will be better oxidized (the ring bearing an electron donating group)

Page 47: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

• The least substituted aromatic ring will be favorably oxidized, especially at the least hindered carbon atom

N

NCl

MeclizineAntiemetic agent

N

NCl

OH

Major metabolite

Page 48: Drug metabolism Refers to enzyme-mediated biotransformations (detoxication) that alter the pharmacological activity of both endogenous and exogenous compounds

• The activated ring will be better oxidized (the ring bearing an electron donating group)

HN

HN

N

Cl

Cl

Clonidine

No aromatic hydroxylation